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Nature has precious treasures for potential cancer therapy. 
Humans with their technical skill have developed several therapies 
against cancer, but we still find some disorders and side effects in 
these artificial therapies. Hence to find more advanced therapy, sev‑
eral researchers try to identify novel materials bestowed in nature. 
Many natural components have incredible potential to cure diseases 
without any adverse side effects, such as the collagenase isolated 
from the King crab (Paralithodes camtschatica) as a the strongest 
antibiotic,[1] the alkaloids from the skin of poison dart frogs (Den‑
drobatidae) toward the development of chemical defense.[2]
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ABSTRACT
Cancer is one of the deadliest diseases against humans. To tackle this menace, humans have developed several high‑technology 
therapies, such as chemotherapy, tomotherapy, targeted therapy, and antibody therapy. However, all these therapies have their own 
adverse side effects. Therefore, recent years have seen increased attention being given to the natural food for complementary therapy, 
which have less side effects. Garlic (大蒜 Dà Suàn; Allium sativum), is one of most powerful food used in many of the civilizations 
for both culinary and medicinal purpose. In general, these foods induce cancer cell death by apoptosis, autophagy, or necrosis. Studies 
have discussed how natural food factors regulate cell survival or death by autophagy in cancer cells. From many literature reviews, 
garlic could not only induce apoptosis but also autophagy in cancer cells. Autophagy, which is called type‑II programmed cell death, 
provides new strategy in cancer therapy. In conclusion, we wish that garlic could be the pioneer food of complementary therapy in 
clinical cancer treatment and increase the life quality of cancer patients.
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Because cancer is the most deadliest disease, recent years 
have seen increased attention being given to cancer cell study.[3] 
Cancer cells are characterized by apoptosis evasion, insensitivity 
to antigrowth signals, tissue invasion or metastasis, and limit‑
less explicative potential.[4] Induction of apoptosis had been the 
dominant research focus in anticancer field for the past decade. 
Therefore, it is important to study tumor microenvironment in 
cancer cells in the future.[5] In this minireview, we focus on the 
regulating mechanisms of apoptosis, autophagy, and necrosis in 
anticancer research. This review is an attempt to update the recent 
research progress related to garlic research against liver cancers 
carried out in the recent years with a special emphasis on the cell 
death process.
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There are three famous types of cell death, which are apop‑
tosis, autophagy, and necrosis, each having their own phenom‑
enon. Cell cycle arrest, DNA fragmentation, caspase activation, 
and apoptosome formation are characteristics of apoptosis.[6] 
However, autophagy, called type‑II programmed cell death, is 
characterized by autophagosome induction, organelles degrada‑
tion, and metabolic stress.[7] As for necrosis, it may accompany 
with inflammation and lesions in cell surface.[8] In this review, 
we concentrate on how active components of garlic regulate 
autophagy in cancer cells.
Garlic and cancer
Garlic (大蒜 Dà Suàn; Allium sativum), a member of Liliaceae 
family is a globally consumed food and is bestowed with immense 
medicinal benefits. Numerous research findings have attributed 
these health benefits mainly resulting from the organosulfur com‑
ponents, such as alliin, γ‑glutamylcysteine, and their derivatives. 
Besides these organosulfur compounds, garlic is rich in trace ele‑
ments (zinc, magnesium, copper, selenium, and iodine), protein 
content, dietary fiber, vitamins, ascorbic acid, and polyphenols. 
Historically almost all the civilizations in the world had knowledge 
of the medicinal properties of garlic and garlic has been used in 
treating a variety of ailments, including leprosy, diarrhea, constipa‑
tion, and infections.[9] However, garlic as a potent anticarcinogen 
came to light in the late 1950s after Weisberger and Pensky demon‑
strated that thiosulfinates extracted from garlic possessed antitumor 
properties.[10] With the therapeutic potential of garlic and the advent 
of modern analytical techniques, there has been a surge in garlic 
research by many research groups around the world.
Classification of autophagy
Four pathways are employed to induce autophagy, including 
macroautophagy, microautophagy, chaperone‑mediated autophagy, 
and crinophagy.[11‑14]
Macroautophagy
Macroautophagy is the most common intracellular degrada‑
tion system in autophagy. In yeast, it starts with the formation of 
preautophagosomal structure (PAS), followed by autophagosome 
formation, whose molecular basis is well‑conserved from yeast to 
higher eukaryotes. The fusion of the autophagosome with lyso‑
somal compartments causes the formation of the digestive vacuole 
of autophagy, known as autophagolysosome.
Microautophagy
The process of microautophagy is nonselective degradation 
process by lysosome engulfing the cell membrane, and then deg‑
radation in the body. So far this situation is often found in yeast.[12]
Chaperone‑mediated autophagy
The process is more complex, involving the recognition of 
the hsc70 complex. By recognition and binding, some unfolding 
proteins may get transferred to lysosome, which then initiates 
degradation, and the target marker from lysosome in chaper‑
one‑mediated autophagy is lysosome‑associated membrane protein 
(LAMP)‑type 2A.[13]
Crinophagy
Crinophagy is a cellular degradation process by which specifi‑
cally secretory granules will be degraded by endocrine secretions 
or hormones.[15] However, the process of crinophagy is still medi‑
ated by the fusion with lysosome.
Molecular mechanism of autophagy signaling transduction
Autophagy is a self‑catabolic process that imparts a survival 
mechanism to cells undergoing nutrient deprivation or other 
stresses, and has been recently linked to the type‑II programmed 
cell death process.[16,17] For example, energy and amino acid ex‑
haustion, unfolding protein response and virus infection stress 
could induce autophagic initiation. Notably, the most dominant 
phenomenon of autophagy is autophagosome formation. Except 
autophagosome formation, the discovery of autophagy‑related 
gene (ATG) could help us to understand the cell signaling trans‑
duction of autophagy. Atg12‑conjugation and LC3‑modification 
are considered to be the necessary protein‑binding systems at 
mammalian autophagosome formation.[18]
ATG family protein and autophagy
ATG5 and ATG12 are located in PAS structure together. 
ATG12 covalently binds ATG5 at a lysine residue. This polymer is 
considered to help double membrane winding. On the other hand, 
LC3 (MAP‑LC3, microtubule‑associated protein 1 light chain 3), a 
small hydrophilic protein (16–18 kDa) located in autophagosome, 
is associated with the formation of autophagolysosome. The cyto‑
solic form of LC3 (LC3‑I) will be proteolytically cleaved to form 
the LC3‑phosphatidylethanolamine conjugate (LC3‑II or LC3B‑II) 
by lysosomes during the conversion of autophagosome to autopha‑
golysosome. More specifically, a C‑terminal glycine 120 of LC3‑I is 
lysed by Cys‑protease ATG4. Then ATG7 and ATG3 will catalyze 
PE bind LC3‑I as LC3‑II (Atg8–PE in yeast). Therefore, most of the 
studies employ the increase in LC3‑II as a biomarker in autophagy 
studies rendering it to be the best biomarker of autophagy.[19]
However, autophagy is not only meditated by ATG family. 
Some studies demonstrated that the mammalian target of rapamy‑
cin (mTOR), Akt/phosphoinositide‑3‑kinase (PI3K) pathway,[20] 
extracellular signal‑regulated kinases (ERK1/2)/p38 mitogen‑ac‑
tivated kinase (p38 MAPK) signaling pathway,[21] Bcl‑2/Beclin‑1 
signaling transduction,[22] and p53 trigger AMP‑activated ki‑
nase (AMPK) have also involved in autophagy.[23]
mTOR signaling transduction
mTOR, a PI3K‑related kinase, acts as a central regulator of 
cell growth in response to nutrients and growth factors. mTOR 
is usually deregulated in cancer cells by dephosphorylating Akt/
PI3K or Akt/protein kinase B (PKB). When mTOR is inhibited, 
the mTOR‑mediated phosphorylation of an autophagy protein 
ATG13 will also be inhibited. Therefore, the hypophosphorylated 
form of ATG13 can interact with ATG1 and ATG17 to form a 
complex, which is essential in the formation of two layers – 
double‑membrane autophagosomes. At the same time, Beclin‑1/
Atg6 will combine with Vps34, a phosphatidylinositol 3‑kinase, 
as a complex to lead to the formation of autophagosome precur‑
sors (vesicle nucleation).[24]
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Mitochondria and autophagy
Bcl‑2/Bcl‑xL, is the most well‑known inhibitor of cell death 
related with mitochondria. For cytoprotective study, Bcl‑2 has 
the ability to antagonize Bax/Bak, block MOMP, and then in‑
hibit apoptosis. Recently, Bcl‑2 was demonstrated to prevent 
autophagy.[25] Because Beclin‑1 can interact with Bcl‑2/Bcl‑xL 
by its Bcl‑2‑homology‑3‑only domain, some research groups 
consider that Bcl‑2 will completely inhibit the binding of Beclin‑1 
and Vps34. In the end, the complex of ATG5‑ATG12 and LC3‑II 
will become autophagosome, and ATG5‑ATG12 will release 
from autophagosome before lysosome binding. Then LC3‑II and 
lysosomes will become autophagolysosome. In addition, the colo‑
calization of LC3‑II with MitoTracker‑red (labeling mitochondria), 
resulting in drug‑induced degradation of mitochondria, could be 
observed by confocal laser microscopy.[26] Autophagosome engulfs 
the mitochondria and this situation is called “Mitophagy.”[27] 
Recent studies indicate that oxidative stress could trigger aerobic 
glycolysis, autophagy, and mitophagy in cancer cells.
p53 signal transduction
p53 gene not only regulates apoptosis but also autophagy.[23] 
When cell incurs some stress or damage, the nuclear p53 will be 
activated and the cytoplasmic p53 protein would be decreased. 
And then the low expression of cytoplasmic p53 protein will ac‑
tivate the phosphorylation of AMPK, which triggers the induction 
of tuberous sclerosis protein 2 (TSC2), and finally TSC2 would 
inhibit the protein expression of mTOR and trigger autophagy.[28] 
However, p53 is a famous tumor suppressor gene and involves in 
many developments of diseases, including cancer. Although p53 
molecular mechanism of autophagy is not clearly understood and 
very complicated, we try to narrow it down in cancer therapy field.
Garlic and autophagy
Many research groups consider that phytochemicals have 
a good potential of cancer chemoprevention.[29] Garlic is one 
such potential phytochemical candidate that has been thoroughly 
studied against various cancer cells, such as colon cancer cells,[30] 
glioblastoma cells,[31] and hepatocarcinoma cells.[32] Most of these 
studies show that apoptosis as the mechanism to be associated 
with the anticancer properties of garlic. However, some studies 
demonstrate that garlic could trigger other phenomena, such as 
autophagy.[33] For example, the crude garlic, which has the protec‑
tive effects on iron‑mediated oxidative stress, proliferation, and 
autophagy in rats.[34] In addition, allicin, which is the most abundant 
component in garlic, could induce autophagic cell death in Hep 
G2 cells.[26] From many research outcomes, it could be perceived 
that garlic with its potent anticancer activities makes it a potential 
complementary medicine in cancer therapy.[35]
CONCLUSION
Autophagy, type‑II programmed cell death, is defined as al‑
terative cancer therapy in addition to apoptosis.[36] However, the 
fate of cell undergoing various types of stress is quite complex, 
and sometimes be contradictory. Even we could not draw the 
whole picture of cell death and survival, we can try our best to find 
complementary therapy, which is much safe and easy in our life.
The risks associated with the side effects of chemotherapy, 
radiation therapy, and surgery, makes us to look for the alternative 
treatments, such as complementary therapy from food or natural 
herbal medicines, such as resveratrol,[37] curcumin,[38] soybean 
fermentation products,[39] and even active components from food 
such as anthocyanins from berries,[40] triteroenes from ginsen‑
oside,[41] which have good tumor inhibition via autophagy and 
have the potential to be an alternative drug in apoptosis‑resistant 
cancer cells.
Garlic, which is considered the most powerful anticarcino‑
genic agent by the Designer Food Program, NCI, 2005, not only 
induces apoptosis but also autophagy in cancer cells. Therefore, 
we try to figure out that garlic has good potential to kill cancer 
cells through apoptosis and induce autophagy in apoptosis‑resisted 
cancer cells [Figure 1]. No matter what mechanism garlic triggers, 
we still consider that garlic as a very good alternative medicine for 
cancer therapy and to be the pioneer in complementary therapy of 
clinical cancer treatment in the future.
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